Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Harvoni
Harvoni
Merck Targets Toughest Cases to Gain Hepatitis C Foothold
Bloomberg
Mon, 08/3/15 - 05:10 pm
Merck
Gilead Sciences
AbbVie
hepatitis C
Viekira Pak
Harvoni
Sovaldi
grazoprevir/elbasvir
Gilead Won’t Run Out of Hep C Patients, or Dollars, Anytime Soon
Bloomberg
Thu, 07/30/15 - 10:36 am
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Gilead hepatitis C drugs build road to Japan
Bizjournals.com
Wed, 07/29/15 - 09:56 pm
Gilead
Japan
hepatitis C
Harvoni
Sovaldi
Eyeing big returns, drugmakers ready new hepatitis-C drug launches
Medical Marketing and Media
Wed, 07/29/15 - 09:46 pm
hepatitis C
Merck
grazoprevir/elbasvir
Gilead Sciences
Harvoni
Sovaldi
Gilead Sciences: Sure, It’s Hep-C But It’s Not Just Hep-C
Barron's
Tue, 07/28/15 - 12:38 am
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Gilead Limits Enrollment in its Hep C Patient Program to Pressure Insurers
WSJ Pharmalot
Thu, 07/16/15 - 04:50 pm
hepatitis C
Gilead Sciences
patients
Harvoni
Sovaldi
Gilead Pills Priced at $1,000 a Day Are Found Cost-Effective
Bloomberg
Mon, 07/13/15 - 10:01 am
Gilead Sciences
drug pricing
hepatitis C
Harvoni
Sovaldi
Fast-paced changes in drugs for hepatitis C seen as harbinger of rising US health care costs
Yahoo/AP
Sat, 07/11/15 - 10:20 am
drug pricing
hepatitis C
Harvoni
Sovaldi
AbbVie
Gilead Sciences
Viekira Pak
Gilead Sciences: Does Anyone Care About Hep-C Anymore?
Barron's
Fri, 07/10/15 - 01:43 pm
Gilead Sciences
hepatitis C
AbbVie
Harvoni
Sovaldi
Viekira Pak
Sanofi, Gilead get boosts in Japan with new Lantus & Harvoni approvals
BioPharma Dive
Tue, 07/7/15 - 10:51 am
Sanofi
Gilead Sciences
Japan
Lantus
Harvoni
diabetes
hepatitis C
Gilead Sciences: New Harvoni Prescriptions Decelerate
Barron's
Fri, 06/19/15 - 05:14 pm
Gilead Sciences
Harvoni
hepatitis C
prescription data
Merck Takes Aim at Gilead. Should You Worry?
Investopedia
Sat, 05/30/15 - 12:27 pm
Merck
Gilead Sciences
Harvoni
Sovaldi
hepatitis C
grazoprevir/elbasvir
Will Gilead's Hepatitis C Dominance Collapse?
Investopedia
Fri, 05/29/15 - 10:21 am
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
JNJ
Consumers Sue Anthem for Denying Coverage for a Gilead Hepatitis C Drug
WSJ Pharmalot
Tue, 05/26/15 - 10:55 am
Gilead Sciences
hepatitis C
Anthem
Harvoni
Gilead Sciences: Hep-C Prescriptions Continue to Fall
Barron's
Fri, 05/22/15 - 12:00 pm
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Hep C patient sues Blue Cross for blocking access to Harvoni
Fierce Pharma
Mon, 05/18/15 - 09:42 pm
hepatitis C
Harvoni
insurance
Gilead Sciences
Gilead: Hep-C Prescriptions Fall, But Quarter Tracking Higher
Barron's
Sat, 05/16/15 - 02:05 pm
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Gilead puts new DTC ads behind its already-stellar Harvoni launch
Fierce Pharma Marketing
Wed, 05/6/15 - 02:00 pm
Gilead Sciences
Harvoni
drug ads
hepatitis C
Gilead EPS Spikes On Harvoni Drug, Latest HCV Fighter
Yahoo/Investors.com
Fri, 05/1/15 - 10:12 am
Gilead Sciences
Harvoni
earnings
Gilead Will Keep Hepatitis C Dominance In Its Grip With Recent Trial Results
Seeking Alpha
Tue, 04/28/15 - 08:49 am
Gilead Sciences
Harvoni
hepatitis C
AbbVie
Bristol-Myers Squibb
Merck
Achillion
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »